CLARENDON HOUSE, HAMILTON, D0
Market cap: $3.3B (2/08/2026)
Price: $44.35
Ross Moat Appointed Chief Operating Officer at Kiniksa Pharmaceuticals
Provides Corporate Update
Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution
Presentation JUNE 2025
Shareholder votes
Earnings Release
News, Material Contracts
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Certification of Termination of Registration of a Class of Security
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
S-8 POS